Drugs Information:
Rufinamide
Basic Information
|
||
ID | DDInter1627 | |
Drug Type | small molecule | |
Molecular Formula | C10H8F2N4O | |
Molecular Weight | 238.194 | |
CAS Number | 106308-44-5 | |
Description | Rufinamide is a triazole derivative and an anticonvulsant medication to treat seizure disorders like Lennox-Gastuat syndrome, a form of childhood epilepsy. Clinical trials suggest its efficacy in the treatment of partial seizures. | |
ATC Classification | N03AF03 | |
IUPAC Name | 1-[(2,6-difluorophenyl)methyl]-1H-1,2,3-triazole-4-carboxamide | |
InChI | POGQSBRIGCQNEG-UHFFFAOYSA-N | |
Canonical SMILES | NC(=O)C1=CN(CC2=C(F)C=CC=C2F)N=N1 | |
Useful Links | DrugBank ChEBI PubChem Substance KEGG Drug ChemSpider PharmGKB Wikipedia ChEMBL ZINC |
Interactions with
Rufinamide
Filter:
Severity level | ID | Name | Mechanism | Detail |
---|
Interactions with diseases
Filter:
Severity level | Disease name | Text | References |
---|
Interactions with foods
Filter:
Severity level | Food name | Description | Management | Mechanism | References |
---|
Interactions with compound preparation
Multi-DRUG trade | Multi-DRUG | Drug type | Warning | Note |
---|